Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
30.63
+2.73 (9.78%)
At close: Mar 9, 2026, 4:00 PM EDT
31.00
+0.37 (1.21%)
After-hours: Mar 9, 2026, 5:45 PM EDT

Capricor Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,584627151977170
Upgrade
Market Cap Growth
129.95%316.72%54.55%37.70%0.89%1046.92%
Upgrade
Enterprise Value
1,465544124543035
Upgrade
Last Close Price
27.9013.804.893.862.933.43
Upgrade
PS Ratio
139.2128.185.9838.19288.92226.06
Upgrade
PB Ratio
15.214.316.668.272.262.49
Upgrade
P/TBV Ratio
18.484.316.668.272.262.49
Upgrade
P/FCF Ratio
---62.58--
Upgrade
P/OCF Ratio
---19.82--
Upgrade
EV/Sales Ratio
131.6624.434.9421.01122.30113.31
Upgrade
EV/FCF Ratio
---34.43--
Upgrade
Debt / Equity Ratio
0.170.010.100.220.090.01
Upgrade
Debt / FCF Ratio
---1.64--
Upgrade
Net Debt / Equity Ratio
-1.00-1.03-1.65-3.30-1.02-1.15
Upgrade
Net Debt / EBITDA Ratio
0.993.651.621.331.552.39
Upgrade
Net Debt / FCF Ratio
1.233.611.35-24.961.783.05
Upgrade
Asset Turnover
0.100.190.460.060.010.01
Upgrade
Quick Ratio
3.507.701.591.788.5411.01
Upgrade
Current Ratio
3.597.771.631.828.8211.33
Upgrade
Return on Equity (ROE)
-107.79%-48.16%-129.63%-134.49%-67.23%-77.95%
Upgrade
Return on Assets (ROA)
-49.39%-23.21%-27.66%-40.60%-34.46%-37.42%
Upgrade
Return on Capital Employed (ROCE)
-88.20%-28.50%-87.70%-112.00%-56.30%-43.30%
Upgrade
Earnings Yield
-5.29%-6.45%-14.80%-29.78%-28.30%-19.47%
Upgrade
FCF Yield
-4.41%-6.62%-18.36%1.60%-25.45%-15.12%
Upgrade
Buyback Yield / Dilution
-43.02%-31.52%-9.06%-6.34%-48.28%-319.55%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.